0
The Rational Clinical Examination | Clinician's Corner

Does This Patient Have Bacterial Peritonitis or Portal Hypertension? How Do I Perform a Paracentesis and Analyze the Results?

Camilla L. Wong, MD, FRCPC; Jayna Holroyd-Leduc, MD, FRCPC; Kevin E. Thorpe, MMath; Sharon E. Straus, MD, MSc, FRCPC
[+] Author Affiliations

Author Affiliations: Division of Geriatric Medicine, University of British Columbia, Vancouver, British Columbia, Canada (Dr Wong); Knowledge Translation Program, Faculty of Medicine, University of Toronto and St Michael's Hospital, Toronto, Ontario, Canada (Dr Holroyd-Leduc, Mr Thorpe, and Dr Straus); Department of Public Health Sciences, University of Toronto (Mr Thorpe); and Divisions of General Internal Medicine and Geriatrics, University of Calgary, Calgary, Alberta, Canada (Drs Holroyd-Leduc and Straus).


JAMA. 2008;299(10):1166-1178. doi:10.1001/jama.299.10.1166
Text Size: A A A
Published online

Context  Abdominal paracenteses are performed in patients with ascites, most commonly to assess for infection or portal hypertension and to manage refractory ascites.

Objectives  To systematically review evidence for paracentesis methods that may decrease risk of adverse events or improve diagnostic yield and to determine the accuracy of ascitic fluid analysis for spontaneous bacterial peritonitis or portal hypertension.

Data Sources  Relevant English-language studies from MEDLINE (1966-April 2007) and EMBASE (1980-April 2007).

Study Selection  Paracentesis studies evaluating interventions (use of preprocedure coagulation parameters, needle type, insertion location, ultrasound guidance, bedside inoculation into blood culture bottles, and use of plasma expanders in therapeutic taps) for reducing adverse events or improving the diagnostic yield, and studies assessing the accuracy of ascitic fluid biochemical analyses for spontaneous bacterial peritonitis or portal hypertension.

Data Extraction  For technique studies, data on intervention and outcome; and for diagnostic studies, data on parameters for diagnosing spontaneous bacterial peritonitis and portal hypertension (ie, ascitic fluid white blood cell and polymorphonuclear leukocyte [PMN] count, ascitic fluid pH, blood–ascitic fluid pH gradient, and serum-ascites albumin gradient).

Data Synthesis  Thirty-seven studies met inclusion criteria: 2 showed that obtaining preprocedure coagulation was likely unnecessary prior to paracentesis; 1 showed the 15-gauge, 3.25-inch needle-cannula results in less multiple peritoneal punctures [P = .05] and termination due to poor fluid return [P = .02] vs a 14-gauge needle in therapeutic paracentesis; 1 showed immediate inoculation of culture bottles improves diagnostic yield vs delayed (from 77% to 100% [95% CI for the difference, 5.3%-40.0%]); 9 evaluated therapeutic paracentesis, performed with or without albumin or nonalbumin plasma expanders, and found no consistent effect on morbidity or mortality; 16 showed the accuracy of biochemical analysis of ascitic fluid in patients suspected of having spontaneous bacterial peritonitis to increase the likelihood of spontaneous bacterial peritonitis (PMN count >250 cells/μL [summary likelihood ratio {LR}, 6.4] 95% CI, 4.6-8.8; ascitic fluid leukocyte count >1000 cells/μL [summary LR, 9.1] 95% CI, 5.5-15.1; pH < 7.35 [summary LR, 9.0] 95% CI, 2.0-40.6; or a blood–ascitic fluid pH gradient ≥ 0.10 [LR, 11.3] 95% CI, 4.3-29.9) and other levels lowered the likelihood (PMN count ≤ 250 cells/μL [summary LR, 0.2] 95% CI, 0.11-0.37; or a blood–ascitic fluid pH gradient < 0.10 [summary LR, 0.12] 95% CI, 0.02-0.77); and 4 showed the diagnostic accuracy of the serum-ascites albumin gradient lowers the likelihood of portal hypertension (< 1.1 g/dL [summary LR, 0.06] 95% CI, 0.02-0.20).

Conclusions  Ascitic fluid should be inoculated into blood culture bottles at the bedside. Spontaneous bacterial peritonitis is more likely at predescribed parameters of ascitic PMN count or blood–ascitic fluid pH, and portal hypertension is less likely below a predescribed serum-ascites albumin gradient.

Figures in this Article

A 44-year-old man with cirrhosis is admitted with fever but has no obvious source of infection. His physical examination reveals ascites and minimal abdominal tenderness.

Why Is This Procedure Important?

In a previous Rational Clinical Examination article, Williams and Simel1 discussed the previous scenario and suggested performing a diagnostic paracentesis to seek for the source of the patient's fever. Ascites is the most common major complication of cirrhosis.2 The syndrome of infected ascites was first recognized and described in the European literature in the early 20th century.2 4 Infection occurs in as many as 27% of cirrhosis patients admitted to the hospital for evaluation and management of symptoms associated with ascites. The presentation of spontaneous bacterial peritonitis can range from silent to overt5 ; however, patients typically have nonspecific symptoms such as nausea, abdominal pain, malaise, fever, or mild confusion. In reports6 from the 1970s, the mortality rate from spontaneous bacterial peritonitis exceeded 90% but recent data7 show a lower mortality rate of 30%. Diagnosis and subsequent treatment of spontaneous bacterial peritonitis depend on the results from a diagnostic paracentesis. Paracentesis is also used in the diagnostic workup for other causes of ascites such as malignancy. Therapeutic paracentesis may be used to manage refractory ascites.

What Adverse Events Can Result From a Paracentesis?

In general, paracentesis is quite safe. Several prospective and retrospective studies of diagnostic and therapeutic paracentesis report on significant bleeding and death (Table 1). The studies are too heterogeneous to allow meaningful meta-analysis but the overall rate of significant bleeding8 15 ranges from 0% to 2.7% and of death9 10 ,12 13 ,16 from 0% to 17%. Variability in bleeding rates may be influenced by preexisting renal dysfunction.12 The heterogeneity in the risk of death is primarily due to a retrospective study of therapeutic paracentesis in hospitalized patients at a tertiary care hospital.16 The risk of death, renal failure, hyponatremia, and hepatic encephalopathy with therapeutic paracentesis are further discussed in “Results” (see “Plasma Expanders in Therapeutic Paracentesis”). A retrospective analysis of 242 consecutive diagnostic paracenteses reported complicated bowel perforation in 0.83% (95% confidence interval [CI], 0.10%-3.0%) and residual catheter tip fragment in 0.41% (95% CI, 0.01%-2.3%).10 The risk of a paracentesis leak is variable from 0% to 23%.8 ,14 ,16

Table Grahic Jump LocationTable 1. Adverse Events in Paracentesis
Contraindications to Performing a Diagnostic Paracentesis

Quiz Ref IDRelative contraindications to paracentesis include an uncooperative patient, skin infection at the proposed puncture site, pregnancy, and severe bowel distension.17 One expert suggests that coagulopathy precludes paracentesis only if there is clinically evident fibrinolysis or disseminated intravascular coagulation.13

Searches of MEDLINE (using Ovid) from 1966 to April 2007 and EMBASE from 1980 to April 2007 identified English-language studies completed in a clinical setting. The search strategy for studies evaluating interventions to optimize success of the procedure used the terms paracentesis, ascites, ascites fluid, needle, thrombocyte count, platelet count, prothrombin time, partial thromboplastin time, bleeding, blood clotting test, blood coagulation tests, hemorrhage, bacterium culture, culture techniques, ultrasonography, and albumin. For studies of test accuracy, the terms paracentesis, ascites fluid, ascites, ascites fluid analysis, peritonitis, portal hypertension, cell count, leukocyte count, neutrophil count, hydrogen-ion concentration, and albumin were used. Additional articles were found by searching the bibliographies of retrieved articles.

Randomized trials of a predominantly adult population undergoing interventions to reduce adverse events from paracentesis and optimize success were included. If no randomized studies were identified, studies of lower quality including cohort, case-control, and case series were retrieved. Primary data or appropriate summary statistics had to be available for inclusion. If necessary, further data were obtained by contacting study authors. Interventions of interest included those that could be used at the time of paracentesis such as measuring coagulation status, use of ultrasound guidance, location of needle insertion, needle design, bedside vs delayed laboratory inoculation in culture bottles, and use of plasma expanders in therapeutic paracentesis. The outcomes of interest included obtaining a sufficient amount of ascitic fluid, number of attempts, and adverse events.

To examine the accuracy of ascitic fluid analysis in patients suspected of having spontaneous bacterial peritonitis or portal hypertension, we included studies with a predominantly adult population that were prospective in design, described the use of an appropriate reference standard, and applied the same index and reference test to all patients. Furthermore, primary data or appropriate summary statistics had to be available. Where necessary, additional data were obtained by contacting study authors. Diagnostic tests of interest included ascitic fluid white blood cell (WBC) count, ascitic polymorphonuclear (PMN) count, ascitic pH, blood–ascitic fluid pH gradient, and serum-ascites albumin gradient. The gradients were calculated by measuring the serum and ascitic fluid specimens obtained on the same day and subtracting the ascitic value from the serum value.

Two reviewers independently reviewed the abstracts and selected relevant publications that met inclusion criteria. Disagreements were resolved by discussion with the third reviewer. In cases of doubt, full-text articles were retrieved for review and discussion. Two investigators then independently reviewed all full-text articles to confirm that inclusion criteria were met. For intervention studies, data were collected on the quality of the study and method used for outcome assessment. For studies of test accuracy, a data collection form was used to extract information on study quality, sampling method, reference standard, presence of blinding, index test, and population demographics. Positive ascitic fluid cultures and invasive portal pressure measurements were used as reference standards for studies on spontaneous bacterial peritonitis and portal hypertension, respectively.

Statistical Analysis

For studies of interventions, a 2-tailed Fisher exact test was used to examine the significance of the association between 2 categorical variables. For studies on the use of plasma expanders, statistical heterogeneity was assessed by the Q test. Odds ratios and absolute risk reductions were determined by using a random-effects model via the Mantel-Haenszel and inverse variance methods for combined and single studies, respectively. For studies of test accuracy, summary likelihood ratios (LRs) were calculated using a random-effects model (DerSimonian and Laird). The summary measures were calculated on the natural logarithm of the LR and then exponentiated to arrive at LRs. If 1 or more studies contained zeros in their 2 × 2 table, resulting in LR estimates of zero or infinity, 0.5 was added to the counts for all studies in that analysis. Statistical analysis was conducted using R (R Foundation for Statistical Computing, Vienna, Austria) version 2.5.0 and the rmeta contributed package version 0.8-2.

Preprocedure Coagulation Studies

Seventy-three citations of potential studies on preprocedure coagulation investigations were found (Figure 1). Five were obtained for full-text review, but 3 were discarded because of retrospective design10 11 and because less than half of the patients had complete coagulation profiles.13 Only 2 prospective studies systematically obtained prothrombin times and platelet counts prior to paracentesis in all patients.8 9

Place holder to copy figure label and caption
Figure 1. Study Selection for Studies on Performing Paracentesis and on Interpreting the Results of Paracentesis
Grahic Jump Location

WBC, white blood cell; PMN, polymorphonuclear leukocyte. Detailed information on literature search is available from authors.
aThe total number of citations identified and excluded based on review of title and abstract is less than the sum of citations shown because of overlapping citations.
bSeven overlapping studies.

The first study included both diagnostic and therapeutic procedures in the emergency department under ultrasound guidance. Patients presenting with concomitant problems requiring transfusion were excluded. No bleeding complications occurred in any of the 96 diagnostic procedures (95% CI, 0%-3.8%), even though 6 paracenteses were carried out with a platelet count of less than 50 000/μL and 27 paracenteses were performed with an international normalized ratio (INR) of more than 1.5. Only 2 episodes of minor bleeding occurred among the 314 therapeutic procedures (0.0064%; 95% CI, 0.0008%-0.023%). Both occurred with an INR of 2.5 to 2.9 and platelet count of 50 000 to 99 000/μL. Neither resulted in hospitalization or transfusion.9

The second study included 1100 large-volume paracenteses performed by trained endoscopy assistants in an outpatient setting. There was no significant bleeding in any patient (95% CI, 0%-0.33%) despite 598 procedures that were performed with a platelet count of less than 50 000/μL and 292 with an INR of greater than 2.0.8

Therefore, preprocedure coagulation studies are likely unnecessary prior to paracentesis.

Location of Paracentesis and Ultrasound Guidance

One hundred forty-eight citations of potential studies on the location of paracentesis or the role of ultrasound guidance were found. Three articles met the inclusion criteria.18 20 In the past, the midline was usually chosen as the site for paracentesis because of its avascularity; however, the ideal site for the procedure remains controversial. This research identified 2 studies that evaluated different locations for possible paracentesis using ultrasonography, but neither study objectively confirmed the site selection with actual paracentesis.18 19 In a study of 52 patients, the investigators compared the abdominal wall thickness and depth of ascites between the subumbilical midline and the left lower quadrant using ultrasonography. The abdominal wall was thicker (P < .0001) and the depth of the ascites shallower (P < .02) at the midline than at the left lower quadrant in the supine position.18 In another study of 27 patients, ascites detected by ultrasonography found the location of the distribution too variable to identify the ideal site for blind puncture, particularly in small or moderate ascites.19

Because the physical examination often fails at detecting smaller amounts of ascites,1 clinicians recognize that the reference standard for detecting ascites is either ultrasonography, which can reveal as little as 100 mL of ascitic fluid,21 or paracentesis. One randomized trial of 100 emergency department patients compared bedside ultrasound-guided paracentesis vs the traditional technique. However, the allocation of randomization was not concealed and the physician performing the procedure completed the randomization by coin toss. The authors did not distinguish between diagnostic vs therapeutic procedures. Of the 56 patients assigned to the ultrasound group, 42 showed identifiable ascites on diagnostic imaging, of whom 40 underwent successful aspiration. In the 44 patients randomized to paracentesis without ultrasound evaluation, 27 underwent successful aspiration. The ultrasound-guided approach yielded a successful aspiration rate of 71% vs 61% without ultrasound (P = .39, using an intention-to-treat analysis). For 15 of the 17 patients in whom the traditional technique failed, the ultrasound technique was later used. In 13 patients, fluid was visualized on ultrasound and all underwent successful aspiration. Therefore, a role may exist for ultrasound guidance when the traditional technique fails. In the same study, the number of passes was recorded in 80 patients. Of these patients, there was no difference in the proportion of patients who required more than 1 attempt between the ultrasound group vs the traditional group (P = 1.00).20

Needle Design

One hundred sixteen citations of potential studies on needle design were identified. Three full-text articles were retrieved.13 14 ,22 There were no randomized studies comparing needle gauge or length. We found 1 prospective study of 229 paracenteses in which the procedure was first attempted with a 1.5-inch, 22-gauge metal needle, and if unsuccessful, it was reattempted with a 3.5-inch, 22-gauge replacement. Seven procedures required ultrasound for localization. Successful aspiration was achieved in 94% of attempts with the shorter needle, and the remaining 6% of attempts with the 3.5-inch needle.13

Two full-text articles describing use of specialized needles were retrieved, but 1 was subsequently discarded because it was not a randomized study.22 In a randomized study of 40 patients with symptomatic ascites, large-volume paracentesis was performed with a 14-gauge, 3.25-inch Angiocath needle with the plastic sheath discarded and compared with use of a 15-gauge, 3.25-inch Caldwell needle/cannula in the other half. Details of the randomization were not clearly stated. Fewer patients in the Caldwell needle/cannula group required multiple peritoneal punctures (1 vs 6; P < .05) and fewer procedures were terminated due to poor fluid return (1 vs 8; P = .02). There was no significant difference in complications or volume of ascites removed.14

Bedside Inoculation

One study that evaluated inoculation of 10 mL of ascitic fluid into blood culture bottles immediately at the bedside vs a 4-hour delayed inoculation in the laboratory was identified.23 Of the 29 sets that grew a pathogenic organism, 7 grew bacteria in the bedside samples only. There were no sets in which the delayed sample grew bacteria and the bedside sample did not. Thus, the yield on delayed inoculation among patients with bacterial infection was 77% vs 100%, favoring immediate inoculation (95% CI for the difference, 5.3%-40.0%). Quiz Ref IDFor every 5 patients who have their ascitic fluid immediately inoculated into a bedside culture bottle vs delayed inoculation by the laboratory, 1 additional patient with bacterial infection will be detected.

Plasma Expanders in Therapeutic Paracentesis

The study strategy identified 1264 citations of potential studies on the use of plasma expanders for therapeutic paracentesis. There was 1 citation in the Cochrane Library; however, it was only at the protocol stage.24 Thirty-six full-text articles were identified for further evaluation and 27 were later excluded for a variety of reasons: comparison was with diuretics,25 27 intervention of interest was reinfusion of concentrated ascitic fluid,28 31 intervention of interest was not a plasma expander,32 33 the authors could not be contacted for primary data,34 and study design was not a randomized trial.35 51 Of the 9 remaining prospective randomized studies,52 60 6 provided details on the methods of randomization52 ,54 57 ,59 and none described the use of blinded outcomes assessment.

All 9 studies with data from 806 procedures, reported hyponatremia and renal impairment as outcomes of interest. The overall incidence of hyponatremia was 0% to 20% and for renal impairment 0% to 8.8%, depending on the definition of outcome and time to outcome used. There was no significant difference between therapeutic paracentesis with and without volume expansion with albumin, nor with nonalbumin plasma expanders compared with albumin for either hyponatremia or renal impairment (Table 2 and Table 3).52 60

Table Grahic Jump LocationTable 2. Adverse Events Associated With Therapeutic Paracentesis Comparing Use of Albumin vs No Plasma Expanders
Table Grahic Jump LocationTable 3. Adverse Events Associated With Therapeutic Paracentesis Comparing Use of 2 Plasma Expanders

Seven studies, with data from 666 procedures, reported encephalopathy as an outcome.52 58 Encephalopathy occurred in 1.7% to 8.6% of procedures, with no significant advantage with and without volume expansion with albumin, nor with nonalbumin plasma expanders compared with albumin (Table 2 and Table 3).

The incidence of death following therapeutic paracentesis was 0% to 13% in 7 studies, which included 678 procedures.53 59 The heterogeneity in the risk of death among the studies was likely due to the different time frames used to define the outcome. In one study, for example, several patients died during hospitalization, several weeks after the procedure.58 Regardless of the outcome definition used, albumin compared with no plasma expansion or other plasma expanders did not confer any statistically significant difference in the risk of death (Table 2 and Table 3).

Therefore, no existing study comparing albumin with other plasma expanders found a difference in morbidity or mortality following paracentesis. However, there is insufficient evidence comparing plasma expanders to either placebo or saline to be certain that there is no benefit.

Interpreting the Results

Ascitic fluid and serum samples can be subjected to various analyses, but this discussion will concentrate on diagnosing spontaneous bacterial peritonitis or portal hypertension—the most common indications for the procedure. The diagnostic accuracy of the tests are summarized as LRs, the likelihood that a given test result would occur in a patient with the target disorder as opposed to a patient without. The reference standard for diagnosing spontaneous bacterial peritonitis remains controversial. For this analysis, a culture with positive results was used as the reference standard, recognizing that there is no consensus on how to interpret bacterascites or what PMN count level should be used to define a culture with negative results for neutrocytic ascites. The diagnosis of a culture with negative results for neutrocytic ascites is given to patients with an elevated PMN count and cultures with negative results. Conversely, a diagnosis of bacterascites is given to patients who have cultures with positive results without an elevation in the PMN count. The literature has identified, not uncommonly, ascitic patients with “mixed” etiology as the cause of ascites with coincidental portal hypertension. Invasive measures of portal pressure was the reference standard for diagnosing portal hypertension.

Ascitic Fluid WBC and PMN Count

Seven hundred sixty-four citations of potential studies on the test accuracy of ascitic fluid WBC and PMN count were found. Twenty-eight full-text articles were identified for further evaluation, and 14 were later excluded for a variety of reasons: retrospective design,61 65 the study examined serum and not ascitic fluid WBC count,66 the study examined lymphocyte count only,67 the authors were contacted but no longer had primary data available,68 70 the authors could not be contacted to clarify if the study was prospective71 or to obtain primary data,5 ,72 or the control group in the study was defined by a PMN count of less than 250 cells/μL.73 Of the remaining 14 prospective studies, all occurred in a clinical setting,74 87 5 clearly described the use of consecutive sampling,75 76 ,80 ,84 ,87 4 missed a minor proportion of individual test data,75 ,79 ,84 85 and none mentioned the use of blinding for either the index or reference test.

The studies used various cut-off points for both parameters (Table 4).74 87 The most accurate parameters to diagnose spontaneous bacterial peritonitis were an ascitic WBC count of greater than 1000 cells/μL (summary LR, 9.1; 95% CI, 5.5-15.1) and an ascitic PMN count of greater than 500 cells/μL (summary LR, 10.6; 95% CI, 6.1-18.3). While the literature supports a threshold of greater than 500 cells/μL as most accurate, most experts initiate antibiotic therapy when the PMN count is greater than 250 cells/μL, given still the greatly increased likelihood of spontaneous bacterial peritonitis at this lower PMN count threshold (summary LR, 6.4; 95% CI, 4.6-8.8) along with the potential fatality of spontaneous bacterial peritonitis.88 89 Quiz Ref IDConversely, an ascitic PMN count of 250 cells/μL or less lowers the likelihood of spontaneous bacterial peritonitis (summary LR, 0.20; 95% CI, 0.11-0.37).

Table Grahic Jump LocationTable 4. Studies Assessing Ascitic Fluid White Blood Cell and Polymorphonuclear Leukocyte Counts for Spontaneous Bacterial Peritonitis
Ascitic Fluid pH and Blood–ascitic Fluid pH Gradient

The search strategy yielded 192 citations and review of these led to inclusion of 9 studies appropriate for data extraction (Table 5).68 ,74 75 ,78 79 ,81 ,83 ,87 ,90 Of the 20 full-text articles reviewed, 11 articles were excluded because the outcome of interest was malignancy and not spontaneous bacterial peritonitis,91 the data were preliminary results of another study,92 the authors were contacted but no longer had primary data available,69 ,72 the reference was an editorial of another study,93 94 the index test was not performed on many patients,82 or the authors could not be contacted to clarify the reference standard used,95 to verify if the study was prospective,71 or for primary data.72 ,77 Of the remaining 9 prospective studies, all occurred in a clinical setting,68 ,74 75 ,78 79 ,81 ,83 ,87 ,90 3 explicitly described use of consecutive sampling,68 ,75 ,87 all but 1 had complete data for index and reference tests,75 and none mentioned the use of blinding for either the index or reference test. The sample sizes were small, ranging from 13 to 285. Of the included studies, the most recent was published in 1995; most other studies meeting inclusion criteria were published more than 20 years ago. We are uncertain about the routine clinical laboratory availability of ascitic fluid pH measurements.

Table Grahic Jump LocationTable 5. Studies Assessing Ascitic Fluid pH and Blood−Ascitic Fluid pH Gradient for Spontaneous Bacterial Peritonitis

An ascitic fluid pH of lower than 7.35 (summary LR, 9.0; 95% CI, 2.0-40.6) and a blood–ascitic fluid pH gradient of 0.10 or greater (LR, 11.3; 95% CI, 4.3-29.9) were the most accurate thresholds for diagnosing spontaneous bacterial peritonitis as evidenced by having the highest diagnostic odds ratios (calculated by positive LR/negative LR). Conversely, a blood–ascitic fluid pH gradient of lower than 0.10 lowers the likelihood of spontaneous bacterial peritonitis (LR 0.12; 95% CI, 0.02-0.77).

The Serum-Ascites Albumin Gradient

One hundred sixteen citations of potential studies on the test accuracy of the serum-ascites albumin gradient were identified. Review of these led to retrieval of 20 full-text articles for assessment and 4 prospective studies were subsequently identified for inclusion.96 99 Reasons for excluding trials were inappropriate choice of reference standard or failure to apply the same reference standard to all patients,95 ,100 105 unclear reference standard,106 commentary publication,107 the serum-ascites albumin gradient was used to study malignancy and not portal hypertension,73 74 ,76 ,91 ,108 109 or retrospective design.110

In the remaining 4 prospective studies,96 99 all were conducted in a clinical environment, 1 clearly described use of consecutive sampling,96 all had complete individual data for both the index and reference test, and none described use of blinded assessment for the index or reference test. Quiz Ref IDPooling the 1029 samples from the 4 studies, an abnormal serum-ascites albumin gradient of 1.1 g/dL or greater (≥11 g/L) increases the likelihood of portal hypertension (summary LR, 4.6; 95% CI, 1.6-12.9). A normal serum-ascites albumin gradient (<1.1 g/dL [<11 g/L]) is very useful in decreasing the likelihood of portal hypertension (summary LR, 0.06; 95% CI, 0.02-0.20) (Table 6).96 99

Table Grahic Jump LocationTable 6. Studies Assessing the Serum-Ascites Albumin Gradient for Portal Hypertensiona
How Should the Procedure Be Performed?

Ideally, a successful paracentesis should meet the following criteria: (1) sufficient fluid is obtained on the first attempt; (2) occurs without adverse events to the patient such as bleeding or bowel perforation; and (3) occurs with minimal discomfort to the patient during and after the procedure. The following description of the method to perform a paracentesis considers the best available evidence and expert opinion to facilitate successful completion.

The procedure, including its risks, should be explained to the patient and informed consent obtained if relevant in the practice setting. The explanation should include how the procedure will be performed, why it is being done, level of experience of the clinician, what complications may occur, and how these can be treated. For example, patients can be told that on average, out of 100 paracenteses, 3 will result in a bleeding complication and 1 in a bowel perforation. The risk of death from a diagnostic paracentesis is less than 1.2%. Patients should be asked if they are allergic to any medications including local anesthesia. The patient should urinate prior to the procedure.

The procedure is usually completed with the patient in the supine position. The head of the bed should be elevated 30° to 45° to allow fluid to accumulate in the patient's lower abdomen.13

The needle insertion site should be localized to the level of percussible dullness on the abdominal wall. To minimize damage to vascular structures, 2 possible sites may be selected: either a site in the midline 2 cm below the umbilicus or the area of flank dullness in the left lower quadrant lateral to the rectus abdominus muscle (Figure 2). The needle should never be inserted through superficial veins or through surgical scars, since scars may have collateral vessels or underlying adherent bowel.13

Place holder to copy figure label and caption
Figure 2. Positioning of Patient and Needle for Diagnostic Paracentesis Using the Z-tract Technique
Grahic Jump Location

To perform a paracentesis, place the patient in a supine position with the head of the bed elevated 30° to 45°. Insert the needle at the level of percussable dullness on the abdominal wall. Preferred sites of needle insertion avoid vascular structures and include the midline 2 cm below the umbilicus or the area of flank dullness in the left lower quadrant lateral to the rectus abdominus muscle. For a diagnostic paracentesis, use a 22-gauge needle attached to a 20 to 50 mL syringe. With the nondominant hand, stretch the skin 1 to 2 cm caudad to the point of insertion and maintain tension. Slowly advance the needle while gently aspirating to allow free return of ascitic fluid once the peritoneal space is entered. After collecting sufficient fluid for analysis, remove the needle rapidly and allow the skin to resume its natural position. Place an adhesive bandage over the insertion site.

Wearing sterile gloves, the clinician should cleanse the puncture site with an antiseptic solution. Sterile drapes can be applied, leaving the puncture site exposed. Using a 25-gauge needle, 1 to 3 mL of local anesthetic should be injected (eg, lidocaine) to infiltrate the skin and then into the subcutaneous tissue. Two minutes should be allowed for the anesthetic to take effect. If performing a diagnostic procedure, a 22-gauge, 1.5-inch needle should be attached to a 20- to 50-mL syringe; and if performing a therapeutic tap, a 15-gauge, 3.25-inch Caldwell needle/cannula should be used. Using the Z-tract method, the abdominal skin should be stretched 1 to 2 cm caudad prior to insertion and tension maintained using the nondominant hand. It is thought that this technique may seal the needle tract and prevent persistent leakage of ascitic fluid, although no evidence supports this. The needle should be slowly advanced at a 45°- or 90°-angle while gently aspirating to allow free return of the ascitic fluid, once the peritoneal space is entered. If using the Caldwell needle/cannula, it should be withdrawn, leaving the outer cannula in place. Some clinicians use the angular technique, in which the needle is inserted at a 45°-angle; however no evidence supports this method.

For a diagnostic sample, an appropriate amount should be aspirated into the large syringe. For a therapeutic tap, an evacuation container should be connected using high-pressure connection tubing. After collecting sufficient fluid for analysis, the apparatus should be rapidly removed allowing the skin to resume its natural position. An adhesive bandage should be placed over the insertion site. If there is leakage of ascitic fluid, a pressure dressing should be applied.

If the first attempt fails, a reattempt should be done with landmarking of another site. If the patient has an excessively thick panniculus, the clinician should change to a 3.5-inch needle of equal gauge. There are also commercially available prepackaged paracentesis kits with catheter-over-needle devices. Alternatively, the procedure may be attempted by another individual or with ultrasound guidance.

Normal ascitic fluid should be clear. Ascitic fluid (10 mL) should be immediately inoculated into 1 aerobic and 1 anaerobic blood culture bottle at the bedside.13 Depending on the purpose of the paracentesis, the remainder of the ascitic fluid can be sent to the laboratory for obtainment of a cell count, Gram stain, pH, and albumin. Serum samples such as arterial pH and albumin that are used to calculate serum-ascitic fluid gradients should be drawn within 30 minutes of the paracentesis.

How Should This Procedure Be Taught or Learned?

The American Board of Internal Medicine no longer recommends 3 directly supervised, successfully performed abdominal paracenteses as a minimum standard of competency.111 Instead, the organization recommends that trainees be able to explain indications, contraindications, patient preparation, sterile techniques, pain management, handling of specimens and fluids obtained, interpretation of test results, and management of complications. These newer standards (revised in 2006 and updated in November 2007) were developed using expert consensus. In a survey, 71% of program directors agreed that all of their residents master the procedure.112 A survey of 242 internal medicine residents found that they needed to complete 3 to 5 procedures to feel confident in their performance.113 In another survey of 128 graduating internal medicine residents, a median of 15 paracenteses were completed at the time of residency completion and 87% of residents felt confident in performing the procedure.114 While performing the paracentesis is not an explicit requirement of the American Board of Internal Medicine, we anticipate that many program directors will encourage their trainees to develop competency in this skill.

Only descriptive studies, with little evaluation of the various methods, provide evidence to guide the teaching of paracentesis. A comprehensive, cadaver-based workshop for first-year internal medicine residents was reported to improve residents' knowledge and comfort level in performing invasive bedside procedures including paracenteses; however, this study evaluated student self-reported data rather than objective measurement of technical skill proficiency.115 Other reports have cited the use of unembalmed cadavers as a useful educational approach to teaching paracentesis; but there has not been any rigorous evaluation of these methods.116 117 One study described the implementation of a pilot medical procedure service. Select faculty ensured familiarity with relevant anatomy, taught residents the psychomotor skills required for a specific procedure, and identified and managed complications. A complementary Web-based, multimedia curriculum outlining the indications, contraindications, risks and benefits, and anatomical landmarks of each procedure was also developed. Experienced hospitalists supervised 37 paracenteses performed by trainees, of which only 1 procedure resulted in serious complication (hemorrhage), for a complication rate (2.7%) consistent with other studies. Eighty-seven percent of the housestaff believed this procedure service helped in their education of medical procedures.118 However, there was no control group with housestaff who did not complete this program available for comparison.

This review highlights several gaps in the literature pertaining to the performance and interpretation of paracentesis. Future areas of study include how to teach and learn the procedure to optimize performance and determination of optimal needle gauge and length, amount of ascites removal at which plasma expanders should be considered, and best procedure location.

The patient in this study had a fever and ascites. Blood work included arterial pH and albumin measurement. A diagnostic paracentesis was completed after obtaining informed consent. Cloudy ascitic fluid was sent to the laboratory to obtain its cell count and differential, pH, albumin, Gram stain and culture. The patient's ascitic fluid PMN count was 623 cells/μL. Broad spectrum antibiotic therapy was initiated for presumed spontaneous bacterial peritonitis while awaiting culture results.

Quiz Ref IDA diagnostic paracentesis should be performed at the time of admission on any patient with ascites, when there is a clinical suspicion of spontaneous bacterial peritonitis. Ascitic fluid should be directly inoculated into blood culture bottles at the bedside.

In patients suspected of having spontaneous bacterial peritonitis, this study describes the appropriate laboratory results that represent greater likelihood of spontaneous bacterial peritonitis (Table 7). In patients with ascites, in whom portal hypertension is considered, a serum-ascites albumin gradient of 1.1 g/dL or greater (≥11 g/L) makes portal hypertension more likely (summary LR, 4.6; 95% CI, 1.6-12.9), while a gradient of less than 1.1 g/dL (<11 g/L) may rule it out when the prior probability estimate of portal hypertension is low (summary LR, 0.06; 95% CI, 0.02-0.20).

Table Grahic Jump LocationTable 7. Summary Positive Likelihood Ratios for Spontaneous Bacterial Peritonitis

Corresponding Author: Sharon E. Straus, MD, MSc, FRCPC, Department of Medicine, Foothills Hospital, 1403 29th St NW, Calgary, AB, Canada T2N 2T9 (sharon.straus@utoronto.ca).

Author Contributions: Dr Straus had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Studyconcept and design: Wong, Holroyd-Leduc, Straus.

Acquisition of data: Wong, Holroyd-Leduc, Straus.

Analysis and interpretation of data: Wong, Thorpe, Holroyd-Leduc, Straus.

Drafting of the manuscript: Wong.

Critical revision of the manuscript for important intellectual content: Wong, Thorpe, Holroyd-Leduc, Straus.

Statistical analysis: Wong, Thorpe.

Administrative, technical, or material support: Wong, Straus.

Financial Disclosures: None reported.

Funding/Support: Dr Straus is supported by a Tier 2 Canada Research Chair and a Health Scholar Award from the Alberta Heritage Foundation for Medical Research.

Role of the Sponsor: There was no external funding obtained for the design and conduct of the study, the collection, management, analysis, or for the interpretation of the data; or for the preparation, review or approval of the manuscript.

Additional Contributions: We thank Laure Perrier and Desiree Chanderbhan for assistance in the search and retrieval of relevant articles as part of their normal duties; David Simel, MD, MHS, Duke University, Durham, North Carolina, for valuable guidance during the course of the study and feedback on earlier drafts of the manuscript; Mark Fitzgerald, MD, Division of Respiratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and Andrew Muir, MD, MHS, Division of Gastroenterology, Duke University, for useful feedback and suggestions on earlier drafts of the manuscript. None of these individuals received additional compensation for their work in association with this article.

Williams JW Jr, Simel DL. The rational clinical examination: does this patient have ascites?  JAMA. 1992;267(19):2645-2648
PubMedCrossRef
Ginés P, Quintero E, Arroyo V,  et al.  Compensated cirrhosis.  Hepatology. 1987;7(1):122-128
PubMedCrossRef
Krencker E. Bacterium coli commune als sepsiserreger in 2 fällen von abdominalerkrankungen.  Munchen Med Wschr. 1907;542095
Menetrier P, Duval R. Peritonite a pneumocoques a forme ascitique chez une malade atteinte de cirrhose atrophique.  Bull Mem Soc Med Hop Paris. 1906;22208
Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis.  Hepatology. 1983;3(4):545-549
PubMed
Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic?  Med Clin North Am. 1975;59(4):963-981
PubMed
Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis–in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998.  Am J Gastroenterol. 2001;96(4):1232-1236
PubMed
Grabau CM, Crago SF, Hoff LK,  et al.  Performance standards for therapeutic abdominal paracentesis.  Hepatology. 2004;40(2):484-488
PubMedCrossRef
Lin CH, Shih FY, Ma MH, Chiang WC, Yang CW, Ko PC. Should bleeding tendency deter abdominal paracentesis?  Dig Liver Dis. 2005;37(12):946-951
PubMedCrossRef
Mallory A, Schaefer JW. Complications of diagnostic paracentesis in patients with liver disease.  JAMA. 1978;239(7):628-630
PubMedCrossRef
McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities.  Transfusion. 1991;31(2):164-171
PubMedCrossRef
Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.  Aliment Pharmacol Ther. 2005;21(5):525-529
PubMedCrossRef
Runyon BA. Paracentesis of ascitic fluid.  Arch Intern Med. 1986;146(11):2259-2261
PubMedCrossRef
Shaheen NJ, Grimm IS. Comparison of the caldwell needle/cannula with angiocath needle in large volume paracentesis.  Am J Gastroenterol. 1996;91(9):1731-1733
PubMed
Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis.  Am J Gastroenterol. 1996;91(2):366-368
PubMed
Duggal P, Farah KF, Anghel G,  et al.  Safety of paracentesis in inpatients.  Clin Nephrol. 2006;66(3):171-176
PubMed
Koffel KK, Reed JS. The technique of abdominal paracentesis.  J Crit Illn. 1986;145-50
Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis.  Liver Int. 2005;25(5):984-986
PubMedCrossRef
Bard C, Lafortune M, Breton G. Ascites: Ultrasound guidance or blind paracentesis?  CMAJ. 1986;135(3):209-210
PubMed
Nazeer SR, Dewbre H, Miller AH. Ultrasound-assisted paracentesis performed by emergency physicians vs the traditional technique.  Am J Emerg Med. 2005;23(3):363-367
PubMedCrossRef
Goldberg BB, Goodman GA, Clearfield HR. Evaluation of ascites by ultrasound.  Radiology. 1970;96(1):15-22
PubMed
Boccia S, Rollo V, Accorsi L, Macario F, Merighi A, Gullini S.  Paracentesis: a new needle for an old technique.  Endoscopy. 1991;23(2):83-84
PubMedCrossRef
Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis.  J Clin Microbiol. 1990;28(12):2811-2812
PubMed
Simonetti RG, Gluud C, Milazzo G, Pagliaro L. Albumin and other plasma expanders for paracentesis treatment of ascites in cirrhotic patients (protocol).  Cochrane Database Syst Rev. 2003;(1):CD004039
CrossRef
Acharya SK, Balwinder S, Padhee AK, Nijhawan S, Tandon BN. Large volume paracentesis and intravenous dextran to treat tense ascites.  J Clin Gastroenterol. 1992;14(1):31-35
PubMedCrossRef
Choi CH, Ahn SH, Kim DY,  et al.  Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.  J Gastroenterol Hepatol. 2005;20(8):1215-1222
PubMedCrossRef
Solà R, Vila MC, Andreu M,  et al.  Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis.  J Hepatol. 1994;20(2):282-288
PubMedCrossRef
Graziotto A, Rossaro L, Inturri P, Salvagnini M. Reinfusion of concentrated ascitic fluid versus total paracentesis.  Dig Dis Sci. 1997;42(8):1708-1714
PubMedCrossRef
Bruno S, Borzio M, Romagnoni M,  et al.  Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites.  BMJ. 1992;304(6843):1655-1658
PubMedCrossRef
Borzio M, Romagnoni M, Sorgato G,  et al.  A simple method for ascites concentration and reinfusion.  Dig Dis Sci. 1995;40(5):1054-1059
PubMedCrossRef
Bernardi M, Rimondi A, Gasbarrini A,  et al.  Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.  J Hepatol. 1994;20(2):289-295
PubMedCrossRef
Singh V, Kumar B, Nain CK,  et al.  Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.  J Intern Med. 2006;260(1):62-68
PubMedCrossRef
Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.  J Gastroenterol Hepatol. 2006;21(1 Pt 2):303-307
PubMedCrossRef
Moreau R, Valla DC, Durand-Zaleski I,  et al.  Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid.  Liver Int. 2006;26(1):46-54
PubMedCrossRef
Antillon MR, Runyon BA. Postparacentesis plasma expansion prevents asymptomatic laboratory abnormalities, but does it have any impact on morbidity or mortality?  Gastroenterology. 1991;101(5):1455-1457
PubMed
Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis.  Dig Liver Dis. 2003;35(9):668-672
PubMedCrossRef
Ascione A, Burroughs AK. Paracentesis for ascites in cirrhotic patients.  Gastroenterol Int. 1990;3120-123
Burroughs AK. Is the use of albumin of value in cirrhosis?  Dig Liver Dis. 2003;35(9):664-667
PubMedCrossRef
Cabrera J, Inglada L, Quintero E,  et al.  Large-volume paracentesis and intravenous saline.  Hepatology. 1991;14(6):1025-1028
PubMedCrossRef
Forouzandeh B, Konicek F, Sheagren JN. Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites.  J Clin Gastroenterol. 1996;22(3):207-210
PubMedCrossRef
Ginès P, Guevara M, De Las Heras D, Arroyo V. Review article: albumin for circulatory support in patients with cirrhosis.  Aliment Pharmacol Ther. 2002;16(suppl 5)  24-31
PubMedCrossRef
Kellerman PS, Linas SL. Large-volume paracentesis in treatment of ascites.  Ann Intern Med. 1990;112(12):889-891
PubMed
Laffi G, Gentilini P, Romanelli RG, La Villa G. Is the use of albumin of value in the treatment of ascites in cirrhosis?  Dig Liver Dis. 2003;35(9):660-663
PubMedCrossRef
Maor Y. The use of albumin in patients with decompensated cirrhosis: the case in favor.  Isr Med Assoc J. 2005;7(2):115-118
PubMed
Patel AS, Gordon SC. Large-volume paracentesis in outpatients.  Ann Intern Med. 1989;110(4):325-326
PubMed
Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.  Am J Gastroenterol. 1997;92(3):394-399
PubMed
Pinto PC, Amerian J, Reynolds TB. Large-volume paracentesis in nonedematous patients with tense ascites.  Hepatology. 1988;8(2):207-210
PubMedCrossRef
Salerno F, Badalamenti S, Incerti P,  et al.  Paracentesis: a re-evaluated procedure in the management of cirrhotic patients with ascites.  Ital J Gastroenterol. 1990;22(1):44-49
PubMed
Schmidt LE, Ring-Larsen H. The use of albumin infusion in decompensated cirrhosis of the liver.  Ugeskr Laeger. 2002;164(9):1196-1202
PubMed
Terg R, Berreta J, Abecasis R, Romero G, Boerr L. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients: a safe and inexpensive option.  Dig Dis Sci. 1992;37(1):79-83
PubMedCrossRef
Vila MC, Coll S, Sola R, Andreu M, Gana J, Marquez J. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.  Am J Gastroenterol. 1999;94(8):2219-2223
PubMedCrossRef
Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.  Eur J Gastroenterol Hepatol. 1998;10(1):5-10
PubMedCrossRef
Fassio E, Terg R, Landeira G,  et al.  Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites.  J Hepatol. 1992;14(2-3):310-316
PubMedCrossRef
García-Compeán D, Zacarías Villarreal J, Bahena Cuevas H,  et al.  Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites.  Liver. 1993;13(5):233-238
PubMed
Ginès P, Tito L, Arroyo V,  et al.  Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.  Gastroenterology. 1988;94(6):1493-1502
PubMed
Ginès A, Fernández-Esparrach G, Monescillo A,  et al.  Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.  Gastroenterology. 1996;111(4):1002-1010
PubMedCrossRef
Planas R, Ginès P, Arroyo V,  et al.  Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis.  Gastroenterology. 1990;99(6):1736-1744
PubMed
Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.  Hepatology. 1991;13(4):707-713
PubMedCrossRef
Sola-Vera J, Minana J, Ricart E,  et al.  Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.  Hepatology. 2003;37(5):1147-1153
PubMedCrossRef
Zhao J, Yuan C, Wang D. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.  Chin Med J (Engl). 2000;113(1):27-30
PubMed
Bar-Meir S, Lerner E, Conn HO. Analysis of ascitic fluid in cirrhosis.  Dig Dis Sci. 1979;24(2):136-144
PubMedCrossRef
Jones SR. The absolute granulocyte count in ascites fluid.  West J Med. 1977;126(5):344-346
PubMed
Lee HH, Carlson RW, Bull DM. Early diagnosis of spontaneous bacterial peritonitis.  Infection. 1987;15(4):232-236
PubMedCrossRef
Mbopi Kéou FX, Bloch F, Buu Hoi A,  et al.  Spontaneous peritonitis in cirrhotic hospital in-patients.  Q J Med. 1992;83(301):401-407
PubMed
Miros M, Kerlin P. Spontaneous bacterial peritonitis and the ascitic fluid polymorph count.  Aust N Z J Med. 1988;18143-147
Antillon MR, Runyon BA. Effect of marked peripheral leukocytosis on the leukocyte count in ascites.  Arch Intern Med. 1991;151(3):509-510
PubMedCrossRef
Mehrotra MP, Saxena KK, Mathur DC. Etiological diagnosis of ascites.  Indian J Med Res. 1972;60(7):1089-1100
PubMed
Attali P, Turner K, Pelletier G, Ink O, Etienne JP. pH of ascitic fluid.  Gastroenterology. 1986;90(5 pt 1):1255-1260
PubMed
Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.  Arch Intern Med. 1978;138(7):1103-1105
PubMedCrossRef
Garcia-Tsao G, Conn HO, Lerner E. The diagnosis of bacterial peritonitis.  Hepatology. 1985;5(1):91-96
PubMedCrossRef
Scemama-Clergue J, Doutrellot-Philippon C, Metreau JM, Teisseire B, Capron D, Dhumeaux D. Ascitic fluid pH in alcoholic cirrhosis.  Gut. 1985;26(4):332-335
PubMedCrossRef
Lee MY, Wang SS, Lu CW,  et al.  Diagnostic parameters for spontaneous bacterial peritonitis in hepatitis B-related cirrhosis.  Chin J Surg. 1994;53(2):71-76
PubMed
Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites.  Hepatology. 1988;8(5):1104-1109
PubMedCrossRef
Albillos A, Cuervas-Mons V, Millan I,  et al.  Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis.  Gastroenterology. 1990;98(1):134-140
PubMed
Almdal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis.  Scand J Gastroenterol. 1987;22(3):295-300
PubMedCrossRef
Colli A, Cocciolo M, Riva C,  et al.  Ascitic fluid analysis in hepatocellular carcinoma.  Cancer. 1993;72(3):677-682
PubMedCrossRef
el-Touny M, Osman L, Abd-el Hamid T, Sabbour MS. Re-evaluation of the value of ascitic fluid pH lactate dehydrogenase and total proteins in the diagnosis of spontaneous bacterial peritonitis (SBP).  J Trop Med Hyg. 1989;92(1):6-9
PubMed
Gitlin N, Stauffer JL, Silvestri RC. The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis.  Hepatology. 1982;2(4):408-411
PubMedCrossRef
Kao HW, Reynolds TB. The diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis.  Hepatology. 1983;3(2):275-276
PubMed
Kline MM, McCallum RW, Guth PH. The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis.  Gastroenterology. 1976;70(3):408-412
PubMed
Rai RR, Acharya SK, Kambam V, Gandhi BM, Tandon BN. Evaluation of ascitic fluid polymorphonuclear count & ascitic fluid pH in early diagnosis of spontaneous bacterial peritonitis.  Indian J Med Res. 1988;87600-604
PubMed
Runyon BA, Antillon MR. Ascitic fluid pH and lactate.  Hepatology. 1991;13(5):929-935
PubMed
Stassen WN, McCullough AJ, Bacon BR,  et al.  Immediate diagnostic criteria for bacterial infection of ascitic fluid.  Gastroenterology. 1986;90(5 pt 1):1247-1254
PubMed
Storgaard JS, Svendsen JH, Hegnhoj J, Krintel JJ, Nielsen PB. Incidence of spontaneous bacterial peritonitis in patients with ascites.  Liver. 1991;11(4):248-252
PubMed
Wang SS, Lu CW, Chao Y,  et al.  Malignancy-related ascites.  J Hepatol. 1994;20(1):79-84
PubMedCrossRef
Wilson JA, Suguitan EA, Cassidy WA, Parker RH, Chan CH. Characteristics of ascitic fluid in the alcoholic cirrhotic.  Dig Dis Sci. 1979;24(8):645-648
PubMedCrossRef
Yang CY, Liaw YF, Chu CM, Sheen IS. White count, pH and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis.  Hepatology. 1985;5(1):85-90
PubMedCrossRef
Rimola A, Garcia-Tsao G, Navasa M,  et al.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis.  J Hepatol. 2000;32(1):142-153
PubMedCrossRef
Runyon BA.Practice Guidelines Committee; American Association for the Study of Liver Diseases (AASLD).  Management of adult patients with ascites due to cirrhosis.  Hepatology. 2004;39(3):841-856
PubMedCrossRef
Sánchez-Lombraña JL, de la Vega J, Fernandez E,  et al.  Tuberculous peritonitis.  Scand J Gastroenterol. 1995;30(1):87-91
PubMedCrossRef
Rana SV, Babu SG, Kocchar R. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.  Med Sci Monit. 2005;11(3):CR136-CR142
PubMed
Attali P, Pelletier G, Douard H, Buffet C, Etienne JP. Ascitic pH and infection in alcoholic cirrhosis.  Gastroenterol Clin Biol. 1984;8(6-7):518-522
PubMed
Conn HO. Acidic ascitic fluid.  Hepatology. 1982;2(4):507-510
PubMedCrossRef
Reynolds TB. Rapid presumptive diagnosis of spontaneous bacterial peritonitis.  Gastroenterology. 1986;90(5 pt 1):1294-1297
PubMed
Bansal S, Kaur K, Bansal AK. Diagnosing ascitic etiology on a biochemical basis.  Hepatogastroenterology. 1998;45(23):1673-1677
PubMed
Dittrich S, Yordi LM, de Mattos AA. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.  Hepatogastroenterology. 2001;48(37):166-168
PubMed
Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease.  J Lab Clin Med. 1983;102(2):260-273
PubMed
Kajani MA, Yoo YK, Alexander JA,  et al.  Serum-ascites albumin gradients in nonalcoholic liver disease.  Dig Dis Sci. 1990;35(1):33-37
PubMedCrossRef
Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.  Ann Intern Med. 1992;117(3):215-220
PubMed
Akriviadis EA, Kapnias D, Hadjigavriel M, Mitsiou A, Goulis J. Serum/ascites albumin gradient.  Scand J Gastroenterol. 1996;31(8):814-817
PubMedCrossRef
Chen SJ, Wang SS, Lu CW,  et al.  Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.  J Gastroenterol Hepatol. 1994;9(4):396-400
PubMedCrossRef
Goyal AK, Goyal SK, Pokharna DS, Sharma SK. Differential diagnosis of ascitic fluid: evaluation and comparison of various biochemical criteria with a special reference to serum ascites albumin concentration gradient and its relation to portal pressure.  Trop Gastroenterol. 1989;10(1):51-55
PubMed
Gupta R, Misra SP, Dwivedi M, Misra V, Kumar S, Gupta SC. Diagnosing ascites.  J Gastroenterol Hepatol. 1995;10(3):295-299
PubMedCrossRef
Mauer K, Manzione NC. Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites. another look.  Dig Dis Sci. 1988;33(10):1208-1212
PubMedCrossRef
Paré P, Talbot J, Hoefs JC. Serum-ascites albumin concentration gradient.  Gastroenterology. 1983;85(2):240-244
PubMed
Cakaloglu Y, Okten A, Yalcin S. Serum-ascites albumin concentration gradient (A-GRAD) in the prediction of portal hypertension in ascitic patients.  Gastroenterology. 1991;100(5 Pt 1):1484-1485
PubMed
Rubin E. Serum-ascitic fluid albumin gradient, portal hypertension, and ascites.  Mayo Clin Proc. 1997;72(5):487
PubMedCrossRef
Lee CM, Changchien CS, Shyu WC, Liaw YF. Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites.  Cancer. 1992;70(8):2057-2060
PubMedCrossRef
Prieto M, Gomez-Lechon MJ, Hoyos M, Castell JV, Carrasco D, Berenguer J. Diagnosis of malignant ascites.  Dig Dis Sci. 1988;33(7):833-838
PubMedCrossRef
Al-Knawy BA. Etiology of ascites and the diagnostic value of serum-ascites albumin gradient in non-alcohol liver disease.  Ann Saudi Med. 1997;17(1):26-28
PubMed
American Board of Internal Medicine.  Become certified by ABIM. http://www.abim.org/certification/. Accessed
Wigton RS, Blank LL, Nicolas JA, Tape TG. Procedural skills training in internal medicine residencies. a survey of program directors.  Ann Intern Med. 1989;111(11):932-938
PubMed
Hicks CM, Gonzalez R, Morton MT, Gibbons RV, Wigton RS, Anderson RJ. Procedural experience and comfort level in internal medicine trainees.  J Gen Intern Med. 2000;15(10):716-722
PubMedCrossRef
Wickstrom GC, Kolar MM, Keyserling TC,  et al.  Confidence of graduating internal medicine residents to perform ambulatory procedures.  J Gen Intern Med. 2000;15(6):361-365
PubMedCrossRef
Oxentenko AS, Ebbert JO, Ward LE, Pankratz VS, Wood KE. A multidimensional workshop using human cadavers to teach bedside procedures.  Teach Learn Med. 2003;15(2):127-130
PubMedCrossRef
Powers LR, Draeger SK. Using workshops to teach residents primary care procedures.  Acad Med. 1992;67(11):743-745
PubMedCrossRef
Weaver ME, Kyrouac JP, Frank S, Rabinovich S. A cadaver workshop to teach medical procedures.  Med Educ. 1986;20(5):407-409
PubMedCrossRef
Smith CC, Gordon CE, Feller-Kopman D,  et al.  Creation of an innovative inpatient medical procedure service and a method to evaluate house staff competency.  J Gen Intern Med. 2004;19(5 pt 2):510-513
PubMedCrossRef

First Page Preview

First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1. Study Selection for Studies on Performing Paracentesis and on Interpreting the Results of Paracentesis
Grahic Jump Location

WBC, white blood cell; PMN, polymorphonuclear leukocyte. Detailed information on literature search is available from authors.
aThe total number of citations identified and excluded based on review of title and abstract is less than the sum of citations shown because of overlapping citations.
bSeven overlapping studies.

Place holder to copy figure label and caption
Figure 2. Positioning of Patient and Needle for Diagnostic Paracentesis Using the Z-tract Technique
Grahic Jump Location

To perform a paracentesis, place the patient in a supine position with the head of the bed elevated 30° to 45°. Insert the needle at the level of percussable dullness on the abdominal wall. Preferred sites of needle insertion avoid vascular structures and include the midline 2 cm below the umbilicus or the area of flank dullness in the left lower quadrant lateral to the rectus abdominus muscle. For a diagnostic paracentesis, use a 22-gauge needle attached to a 20 to 50 mL syringe. With the nondominant hand, stretch the skin 1 to 2 cm caudad to the point of insertion and maintain tension. Slowly advance the needle while gently aspirating to allow free return of ascitic fluid once the peritoneal space is entered. After collecting sufficient fluid for analysis, remove the needle rapidly and allow the skin to resume its natural position. Place an adhesive bandage over the insertion site.

Tables

Table Grahic Jump LocationTable 1. Adverse Events in Paracentesis
Table Grahic Jump LocationTable 2. Adverse Events Associated With Therapeutic Paracentesis Comparing Use of Albumin vs No Plasma Expanders
Table Grahic Jump LocationTable 3. Adverse Events Associated With Therapeutic Paracentesis Comparing Use of 2 Plasma Expanders
Table Grahic Jump LocationTable 4. Studies Assessing Ascitic Fluid White Blood Cell and Polymorphonuclear Leukocyte Counts for Spontaneous Bacterial Peritonitis
Table Grahic Jump LocationTable 5. Studies Assessing Ascitic Fluid pH and Blood−Ascitic Fluid pH Gradient for Spontaneous Bacterial Peritonitis
Table Grahic Jump LocationTable 6. Studies Assessing the Serum-Ascites Albumin Gradient for Portal Hypertensiona
Table Grahic Jump LocationTable 7. Summary Positive Likelihood Ratios for Spontaneous Bacterial Peritonitis

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Williams JW Jr, Simel DL. The rational clinical examination: does this patient have ascites?  JAMA. 1992;267(19):2645-2648
PubMedCrossRef
Ginés P, Quintero E, Arroyo V,  et al.  Compensated cirrhosis.  Hepatology. 1987;7(1):122-128
PubMedCrossRef
Krencker E. Bacterium coli commune als sepsiserreger in 2 fällen von abdominalerkrankungen.  Munchen Med Wschr. 1907;542095
Menetrier P, Duval R. Peritonite a pneumocoques a forme ascitique chez une malade atteinte de cirrhose atrophique.  Bull Mem Soc Med Hop Paris. 1906;22208
Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis.  Hepatology. 1983;3(4):545-549
PubMed
Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic?  Med Clin North Am. 1975;59(4):963-981
PubMed
Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis–in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998.  Am J Gastroenterol. 2001;96(4):1232-1236
PubMed
Grabau CM, Crago SF, Hoff LK,  et al.  Performance standards for therapeutic abdominal paracentesis.  Hepatology. 2004;40(2):484-488
PubMedCrossRef
Lin CH, Shih FY, Ma MH, Chiang WC, Yang CW, Ko PC. Should bleeding tendency deter abdominal paracentesis?  Dig Liver Dis. 2005;37(12):946-951
PubMedCrossRef
Mallory A, Schaefer JW. Complications of diagnostic paracentesis in patients with liver disease.  JAMA. 1978;239(7):628-630
PubMedCrossRef
McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities.  Transfusion. 1991;31(2):164-171
PubMedCrossRef
Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.  Aliment Pharmacol Ther. 2005;21(5):525-529
PubMedCrossRef
Runyon BA. Paracentesis of ascitic fluid.  Arch Intern Med. 1986;146(11):2259-2261
PubMedCrossRef
Shaheen NJ, Grimm IS. Comparison of the caldwell needle/cannula with angiocath needle in large volume paracentesis.  Am J Gastroenterol. 1996;91(9):1731-1733
PubMed
Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis.  Am J Gastroenterol. 1996;91(2):366-368
PubMed
Duggal P, Farah KF, Anghel G,  et al.  Safety of paracentesis in inpatients.  Clin Nephrol. 2006;66(3):171-176
PubMed
Koffel KK, Reed JS. The technique of abdominal paracentesis.  J Crit Illn. 1986;145-50
Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis.  Liver Int. 2005;25(5):984-986
PubMedCrossRef
Bard C, Lafortune M, Breton G. Ascites: Ultrasound guidance or blind paracentesis?  CMAJ. 1986;135(3):209-210
PubMed
Nazeer SR, Dewbre H, Miller AH. Ultrasound-assisted paracentesis performed by emergency physicians vs the traditional technique.  Am J Emerg Med. 2005;23(3):363-367
PubMedCrossRef
Goldberg BB, Goodman GA, Clearfield HR. Evaluation of ascites by ultrasound.  Radiology. 1970;96(1):15-22
PubMed
Boccia S, Rollo V, Accorsi L, Macario F, Merighi A, Gullini S.  Paracentesis: a new needle for an old technique.  Endoscopy. 1991;23(2):83-84
PubMedCrossRef
Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis.  J Clin Microbiol. 1990;28(12):2811-2812
PubMed
Simonetti RG, Gluud C, Milazzo G, Pagliaro L. Albumin and other plasma expanders for paracentesis treatment of ascites in cirrhotic patients (protocol).  Cochrane Database Syst Rev. 2003;(1):CD004039
CrossRef
Acharya SK, Balwinder S, Padhee AK, Nijhawan S, Tandon BN. Large volume paracentesis and intravenous dextran to treat tense ascites.  J Clin Gastroenterol. 1992;14(1):31-35
PubMedCrossRef
Choi CH, Ahn SH, Kim DY,  et al.  Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.  J Gastroenterol Hepatol. 2005;20(8):1215-1222
PubMedCrossRef
Solà R, Vila MC, Andreu M,  et al.  Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis.  J Hepatol. 1994;20(2):282-288
PubMedCrossRef
Graziotto A, Rossaro L, Inturri P, Salvagnini M. Reinfusion of concentrated ascitic fluid versus total paracentesis.  Dig Dis Sci. 1997;42(8):1708-1714
PubMedCrossRef
Bruno S, Borzio M, Romagnoni M,  et al.  Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites.  BMJ. 1992;304(6843):1655-1658
PubMedCrossRef
Borzio M, Romagnoni M, Sorgato G,  et al.  A simple method for ascites concentration and reinfusion.  Dig Dis Sci. 1995;40(5):1054-1059
PubMedCrossRef
Bernardi M, Rimondi A, Gasbarrini A,  et al.  Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.  J Hepatol. 1994;20(2):289-295
PubMedCrossRef
Singh V, Kumar B, Nain CK,  et al.  Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.  J Intern Med. 2006;260(1):62-68
PubMedCrossRef
Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.  J Gastroenterol Hepatol. 2006;21(1 Pt 2):303-307
PubMedCrossRef
Moreau R, Valla DC, Durand-Zaleski I,  et al.  Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid.  Liver Int. 2006;26(1):46-54
PubMedCrossRef
Antillon MR, Runyon BA. Postparacentesis plasma expansion prevents asymptomatic laboratory abnormalities, but does it have any impact on morbidity or mortality?  Gastroenterology. 1991;101(5):1455-1457
PubMed
Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis.  Dig Liver Dis. 2003;35(9):668-672
PubMedCrossRef
Ascione A, Burroughs AK. Paracentesis for ascites in cirrhotic patients.  Gastroenterol Int. 1990;3120-123
Burroughs AK. Is the use of albumin of value in cirrhosis?  Dig Liver Dis. 2003;35(9):664-667
PubMedCrossRef
Cabrera J, Inglada L, Quintero E,  et al.  Large-volume paracentesis and intravenous saline.  Hepatology. 1991;14(6):1025-1028
PubMedCrossRef
Forouzandeh B, Konicek F, Sheagren JN. Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites.  J Clin Gastroenterol. 1996;22(3):207-210
PubMedCrossRef
Ginès P, Guevara M, De Las Heras D, Arroyo V. Review article: albumin for circulatory support in patients with cirrhosis.  Aliment Pharmacol Ther. 2002;16(suppl 5)  24-31
PubMedCrossRef
Kellerman PS, Linas SL. Large-volume paracentesis in treatment of ascites.  Ann Intern Med. 1990;112(12):889-891
PubMed
Laffi G, Gentilini P, Romanelli RG, La Villa G. Is the use of albumin of value in the treatment of ascites in cirrhosis?  Dig Liver Dis. 2003;35(9):660-663
PubMedCrossRef
Maor Y. The use of albumin in patients with decompensated cirrhosis: the case in favor.  Isr Med Assoc J. 2005;7(2):115-118
PubMed
Patel AS, Gordon SC. Large-volume paracentesis in outpatients.  Ann Intern Med. 1989;110(4):325-326
PubMed
Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.  Am J Gastroenterol. 1997;92(3):394-399
PubMed
Pinto PC, Amerian J, Reynolds TB. Large-volume paracentesis in nonedematous patients with tense ascites.  Hepatology. 1988;8(2):207-210
PubMedCrossRef
Salerno F, Badalamenti S, Incerti P,  et al.  Paracentesis: a re-evaluated procedure in the management of cirrhotic patients with ascites.  Ital J Gastroenterol. 1990;22(1):44-49
PubMed
Schmidt LE, Ring-Larsen H. The use of albumin infusion in decompensated cirrhosis of the liver.  Ugeskr Laeger. 2002;164(9):1196-1202
PubMed
Terg R, Berreta J, Abecasis R, Romero G, Boerr L. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients: a safe and inexpensive option.  Dig Dis Sci. 1992;37(1):79-83
PubMedCrossRef
Vila MC, Coll S, Sola R, Andreu M, Gana J, Marquez J. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.  Am J Gastroenterol. 1999;94(8):2219-2223
PubMedCrossRef
Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.  Eur J Gastroenterol Hepatol. 1998;10(1):5-10
PubMedCrossRef
Fassio E, Terg R, Landeira G,  et al.  Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites.  J Hepatol. 1992;14(2-3):310-316
PubMedCrossRef
García-Compeán D, Zacarías Villarreal J, Bahena Cuevas H,  et al.  Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites.  Liver. 1993;13(5):233-238
PubMed
Ginès P, Tito L, Arroyo V,  et al.  Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.  Gastroenterology. 1988;94(6):1493-1502
PubMed
Ginès A, Fernández-Esparrach G, Monescillo A,  et al.  Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.  Gastroenterology. 1996;111(4):1002-1010
PubMedCrossRef
Planas R, Ginès P, Arroyo V,  et al.  Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis.  Gastroenterology. 1990;99(6):1736-1744
PubMed
Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.  Hepatology. 1991;13(4):707-713
PubMedCrossRef
Sola-Vera J, Minana J, Ricart E,  et al.  Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.  Hepatology. 2003;37(5):1147-1153
PubMedCrossRef
Zhao J, Yuan C, Wang D. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.  Chin Med J (Engl). 2000;113(1):27-30
PubMed
Bar-Meir S, Lerner E, Conn HO. Analysis of ascitic fluid in cirrhosis.  Dig Dis Sci. 1979;24(2):136-144
PubMedCrossRef
Jones SR. The absolute granulocyte count in ascites fluid.  West J Med. 1977;126(5):344-346
PubMed
Lee HH, Carlson RW, Bull DM. Early diagnosis of spontaneous bacterial peritonitis.  Infection. 1987;15(4):232-236
PubMedCrossRef
Mbopi Kéou FX, Bloch F, Buu Hoi A,  et al.  Spontaneous peritonitis in cirrhotic hospital in-patients.  Q J Med. 1992;83(301):401-407
PubMed
Miros M, Kerlin P. Spontaneous bacterial peritonitis and the ascitic fluid polymorph count.  Aust N Z J Med. 1988;18143-147
Antillon MR, Runyon BA. Effect of marked peripheral leukocytosis on the leukocyte count in ascites.  Arch Intern Med. 1991;151(3):509-510
PubMedCrossRef
Mehrotra MP, Saxena KK, Mathur DC. Etiological diagnosis of ascites.  Indian J Med Res. 1972;60(7):1089-1100
PubMed
Attali P, Turner K, Pelletier G, Ink O, Etienne JP. pH of ascitic fluid.  Gastroenterology. 1986;90(5 pt 1):1255-1260
PubMed
Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.  Arch Intern Med. 1978;138(7):1103-1105
PubMedCrossRef
Garcia-Tsao G, Conn HO, Lerner E. The diagnosis of bacterial peritonitis.  Hepatology. 1985;5(1):91-96
PubMedCrossRef
Scemama-Clergue J, Doutrellot-Philippon C, Metreau JM, Teisseire B, Capron D, Dhumeaux D. Ascitic fluid pH in alcoholic cirrhosis.  Gut. 1985;26(4):332-335
PubMedCrossRef
Lee MY, Wang SS, Lu CW,  et al.  Diagnostic parameters for spontaneous bacterial peritonitis in hepatitis B-related cirrhosis.  Chin J Surg. 1994;53(2):71-76
PubMed
Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites.  Hepatology. 1988;8(5):1104-1109
PubMedCrossRef
Albillos A, Cuervas-Mons V, Millan I,  et al.  Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis.  Gastroenterology. 1990;98(1):134-140
PubMed
Almdal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis.  Scand J Gastroenterol. 1987;22(3):295-300
PubMedCrossRef
Colli A, Cocciolo M, Riva C,  et al.  Ascitic fluid analysis in hepatocellular carcinoma.  Cancer. 1993;72(3):677-682
PubMedCrossRef
el-Touny M, Osman L, Abd-el Hamid T, Sabbour MS. Re-evaluation of the value of ascitic fluid pH lactate dehydrogenase and total proteins in the diagnosis of spontaneous bacterial peritonitis (SBP).  J Trop Med Hyg. 1989;92(1):6-9
PubMed
Gitlin N, Stauffer JL, Silvestri RC. The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis.  Hepatology. 1982;2(4):408-411
PubMedCrossRef
Kao HW, Reynolds TB. The diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis.  Hepatology. 1983;3(2):275-276
PubMed
Kline MM, McCallum RW, Guth PH. The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis.  Gastroenterology. 1976;70(3):408-412
PubMed
Rai RR, Acharya SK, Kambam V, Gandhi BM, Tandon BN. Evaluation of ascitic fluid polymorphonuclear count & ascitic fluid pH in early diagnosis of spontaneous bacterial peritonitis.  Indian J Med Res. 1988;87600-604
PubMed
Runyon BA, Antillon MR. Ascitic fluid pH and lactate.  Hepatology. 1991;13(5):929-935
PubMed
Stassen WN, McCullough AJ, Bacon BR,  et al.  Immediate diagnostic criteria for bacterial infection of ascitic fluid.  Gastroenterology. 1986;90(5 pt 1):1247-1254
PubMed
Storgaard JS, Svendsen JH, Hegnhoj J, Krintel JJ, Nielsen PB. Incidence of spontaneous bacterial peritonitis in patients with ascites.  Liver. 1991;11(4):248-252
PubMed
Wang SS, Lu CW, Chao Y,  et al.  Malignancy-related ascites.  J Hepatol. 1994;20(1):79-84
PubMedCrossRef
Wilson JA, Suguitan EA, Cassidy WA, Parker RH, Chan CH. Characteristics of ascitic fluid in the alcoholic cirrhotic.  Dig Dis Sci. 1979;24(8):645-648
PubMedCrossRef
Yang CY, Liaw YF, Chu CM, Sheen IS. White count, pH and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis.  Hepatology. 1985;5(1):85-90
PubMedCrossRef
Rimola A, Garcia-Tsao G, Navasa M,  et al.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis.  J Hepatol. 2000;32(1):142-153
PubMedCrossRef
Runyon BA.Practice Guidelines Committee; American Association for the Study of Liver Diseases (AASLD).  Management of adult patients with ascites due to cirrhosis.  Hepatology. 2004;39(3):841-856
PubMedCrossRef
Sánchez-Lombraña JL, de la Vega J, Fernandez E,  et al.  Tuberculous peritonitis.  Scand J Gastroenterol. 1995;30(1):87-91
PubMedCrossRef
Rana SV, Babu SG, Kocchar R. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.  Med Sci Monit. 2005;11(3):CR136-CR142
PubMed
Attali P, Pelletier G, Douard H, Buffet C, Etienne JP. Ascitic pH and infection in alcoholic cirrhosis.  Gastroenterol Clin Biol. 1984;8(6-7):518-522
PubMed
Conn HO. Acidic ascitic fluid.  Hepatology. 1982;2(4):507-510
PubMedCrossRef
Reynolds TB. Rapid presumptive diagnosis of spontaneous bacterial peritonitis.  Gastroenterology. 1986;90(5 pt 1):1294-1297
PubMed
Bansal S, Kaur K, Bansal AK. Diagnosing ascitic etiology on a biochemical basis.  Hepatogastroenterology. 1998;45(23):1673-1677
PubMed
Dittrich S, Yordi LM, de Mattos AA. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.  Hepatogastroenterology. 2001;48(37):166-168
PubMed
Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease.  J Lab Clin Med. 1983;102(2):260-273
PubMed
Kajani MA, Yoo YK, Alexander JA,  et al.  Serum-ascites albumin gradients in nonalcoholic liver disease.  Dig Dis Sci. 1990;35(1):33-37
PubMedCrossRef
Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.  Ann Intern Med. 1992;117(3):215-220
PubMed
Akriviadis EA, Kapnias D, Hadjigavriel M, Mitsiou A, Goulis J. Serum/ascites albumin gradient.  Scand J Gastroenterol. 1996;31(8):814-817
PubMedCrossRef
Chen SJ, Wang SS, Lu CW,  et al.  Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.  J Gastroenterol Hepatol. 1994;9(4):396-400
PubMedCrossRef
Goyal AK, Goyal SK, Pokharna DS, Sharma SK. Differential diagnosis of ascitic fluid: evaluation and comparison of various biochemical criteria with a special reference to serum ascites albumin concentration gradient and its relation to portal pressure.  Trop Gastroenterol. 1989;10(1):51-55
PubMed
Gupta R, Misra SP, Dwivedi M, Misra V, Kumar S, Gupta SC. Diagnosing ascites.  J Gastroenterol Hepatol. 1995;10(3):295-299
PubMedCrossRef
Mauer K, Manzione NC. Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites. another look.  Dig Dis Sci. 1988;33(10):1208-1212
PubMedCrossRef
Paré P, Talbot J, Hoefs JC. Serum-ascites albumin concentration gradient.  Gastroenterology. 1983;85(2):240-244
PubMed
Cakaloglu Y, Okten A, Yalcin S. Serum-ascites albumin concentration gradient (A-GRAD) in the prediction of portal hypertension in ascitic patients.  Gastroenterology. 1991;100(5 Pt 1):1484-1485
PubMed
Rubin E. Serum-ascitic fluid albumin gradient, portal hypertension, and ascites.  Mayo Clin Proc. 1997;72(5):487
PubMedCrossRef
Lee CM, Changchien CS, Shyu WC, Liaw YF. Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites.  Cancer. 1992;70(8):2057-2060
PubMedCrossRef
Prieto M, Gomez-Lechon MJ, Hoyos M, Castell JV, Carrasco D, Berenguer J. Diagnosis of malignant ascites.  Dig Dis Sci. 1988;33(7):833-838
PubMedCrossRef
Al-Knawy BA. Etiology of ascites and the diagnostic value of serum-ascites albumin gradient in non-alcohol liver disease.  Ann Saudi Med. 1997;17(1):26-28
PubMed
American Board of Internal Medicine.  Become certified by ABIM. http://www.abim.org/certification/. Accessed
Wigton RS, Blank LL, Nicolas JA, Tape TG. Procedural skills training in internal medicine residencies. a survey of program directors.  Ann Intern Med. 1989;111(11):932-938
PubMed
Hicks CM, Gonzalez R, Morton MT, Gibbons RV, Wigton RS, Anderson RJ. Procedural experience and comfort level in internal medicine trainees.  J Gen Intern Med. 2000;15(10):716-722
PubMedCrossRef
Wickstrom GC, Kolar MM, Keyserling TC,  et al.  Confidence of graduating internal medicine residents to perform ambulatory procedures.  J Gen Intern Med. 2000;15(6):361-365
PubMedCrossRef
Oxentenko AS, Ebbert JO, Ward LE, Pankratz VS, Wood KE. A multidimensional workshop using human cadavers to teach bedside procedures.  Teach Learn Med. 2003;15(2):127-130
PubMedCrossRef
Powers LR, Draeger SK. Using workshops to teach residents primary care procedures.  Acad Med. 1992;67(11):743-745
PubMedCrossRef
Weaver ME, Kyrouac JP, Frank S, Rabinovich S. A cadaver workshop to teach medical procedures.  Med Educ. 1986;20(5):407-409
PubMedCrossRef
Smith CC, Gordon CE, Feller-Kopman D,  et al.  Creation of an innovative inpatient medical procedure service and a method to evaluate house staff competency.  J Gen Intern Med. 2004;19(5 pt 2):510-513
PubMedCrossRef
CME Course for: Does This Patient Have Bacterial Peritonitis or Portal Hypertension? How Do I Perform a Paracentesis and Analyze the Results?


You need to register in order to view this quiz.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Ascites

The Rational Clinical Examination
Make the Diagnosis: Ascites